| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antimicrobial resistance: a problem across the cancer care continuum
|
Shropshire, William C
|
|
|
26 |
5 |
p. 537-538
|
artikel
|
| 2 |
Antimicrobial resistance in patients with haematological malignancies: a scoping review
|
Sallah, Ya Haddy
|
|
|
26 |
5 |
p. e242-e252
|
artikel
|
| 3 |
Belzutifan for von Hippel-Lindau disease-associated renal cell carcinoma and other neoplasms (LITESPARK-004): 50 months follow-up from a single-arm, phase 2 study
|
Srinivasan, Ramaprasad
|
|
|
26 |
5 |
p. 571-582
|
artikel
|
| 4 |
Belzutifan in von Hippel-Lindau disease
|
Ciccarese, Chiara
|
|
|
26 |
5 |
p. 531-533
|
artikel
|
| 5 |
Beyond symbolism: embassies, equity, and the cancer equation
|
Adepoju, Paul
|
|
|
26 |
5 |
p. 556-557
|
artikel
|
| 6 |
Bortezomib, melphalan, and prednisone with or without daratumumab in transplant-ineligible patients with newly diagnosed multiple myeloma (ALCYONE): final analysis of an open-label, randomised, multicentre, phase 3 trial
|
Mateos, Maria-Victoria
|
|
|
26 |
5 |
p. 596-608
|
artikel
|
| 7 |
Carcinogenicity of automotive gasoline and some oxygenated gasoline additives
|
Turner, Michelle C
|
|
|
26 |
5 |
p. 548-549
|
artikel
|
| 8 |
Chemotherapy-free neoadjuvant pembrolizumab combined with trastuzumab and pertuzumab in HER2-enriched early breast cancer (WSG-KEYRICHED-1): a single-arm, phase 2 trial
|
Kuemmel, Sherko
|
|
|
26 |
5 |
p. 629-640
|
artikel
|
| 9 |
Circulating tumour DNA and melanoma: time to take the leap?
|
Wilting, Saskia M
|
|
|
26 |
5 |
p. 538-540
|
artikel
|
| 10 |
Clinical validation of droplet digital PCR assays in detecting BRAF V600-mutant circulating tumour DNA as a prognostic biomarker in patients with resected stage III melanoma receiving adjuvant therapy (COMBI-AD): a biomarker analysis from a double-blind, randomised phase 3 trial
|
Syeda, Mahrukh M
|
|
|
26 |
5 |
p. 641-653
|
artikel
|
| 11 |
Concern for cancer drugs in USA–EU tariff war
|
Devi, Sharmila
|
|
|
26 |
5 |
p. 550
|
artikel
|
| 12 |
Correction to Lancet Oncol 2025; 26: 200–13
|
|
|
|
26 |
5 |
p. e238
|
artikel
|
| 13 |
Correction to Lancet Oncol 2025; 26: 609–19
|
|
|
|
26 |
5 |
p. e238
|
artikel
|
| 14 |
Correction to Lancet Oncol 2021; 22: 1530–40
|
|
|
|
26 |
5 |
p. e238
|
artikel
|
| 15 |
Correction to Lancet Oncol 2025: published online April 14. https://doi.org/10.1016/S1470-2045(25)00150
|
|
|
|
26 |
5 |
p. e238
|
artikel
|
| 16 |
Defining the role of pragmatic clinical trials in cancer clinical research: outcomes of a collaborative workshop hosted by the European Organisation for Research and Treatment of Cancer
|
Cardoso Borges, Fábio
|
|
|
26 |
5 |
p. e253-e263
|
artikel
|
| 17 |
Destruction of Gaza's only cancer specialist hospital
|
Burki, Talha
|
|
|
26 |
5 |
p. 551
|
artikel
|
| 18 |
Determining the optimal use of approved drugs in oncology
|
Bouche, Gauthier
|
|
|
26 |
5 |
p. e282-e294
|
artikel
|
| 19 |
Experts aim to boost gynaecological cancer research in Australia and beyond
|
Kirby, Tony
|
|
|
26 |
5 |
p. e239
|
artikel
|
| 20 |
Incidence and prevalence of antimicrobial resistance in outpatients with cancer: a multicentre, retrospective, cohort study
|
Gupta, Vikas
|
|
|
26 |
5 |
p. 620-628
|
artikel
|
| 21 |
International consensus on laryngeal preservation strategies in laryngeal and hypopharyngeal cancer
|
Ferrari, Marco
|
|
|
26 |
5 |
p. e264-e281
|
artikel
|
| 22 |
Limitations in the meta-analysis of prostate radiotherapy-associated toxicity
|
Liang, Zongjian
|
|
|
26 |
5 |
p. e233
|
artikel
|
| 23 |
Limitations in the meta-analysis of prostate radiotherapy-associated toxicity – Authors' reply
|
Kishan, Amar U
|
|
|
26 |
5 |
p. e234
|
artikel
|
| 24 |
Living within our means: trouble ahead for England's cancer planning
|
Lawler, Mark
|
|
|
26 |
5 |
p. 543-544
|
artikel
|
| 25 |
Local anaesthetic transperineal biopsy versus transrectal prostate biopsy in prostate cancer detection (TRANSLATE): a multicentre, randomised, controlled trial
|
Bryant, Richard J
|
|
|
26 |
5 |
p. 583-595
|
artikel
|
| 26 |
Low-dose CT for lung cancer screening in a high-risk population (SUMMIT): a prospective, longitudinal cohort study
|
Bhamani, Amyn
|
|
|
26 |
5 |
p. 609-619
|
artikel
|
| 27 |
Lung cancer screening implementation: turning evidence into practice
|
Heuvelmans, Marjolein A
|
|
|
26 |
5 |
p. 535-537
|
artikel
|
| 28 |
Meta-analysis on SBRT and ablation for localised RCC
|
Chan, Vinson Wai-Shun
|
|
|
26 |
5 |
p. e235-e236
|
artikel
|
| 29 |
Meta-analysis on SBRT and ablation for localised RCC – Authors' reply
|
Huang, Ryan S
|
|
|
26 |
5 |
p. e237
|
artikel
|
| 30 |
Monstrosity of Tiny Tumours: an artist's journey through breast cancer
|
Gruber, Karl
|
|
|
26 |
5 |
p. 558
|
artikel
|
| 31 |
Myung-Ju Ahn: battling sexism in medicine and supporting the next generation
|
Wilkinson, Emma
|
|
|
26 |
5 |
p. 555
|
artikel
|
| 32 |
NHS investment boosts cancer detection for 80 000 patients
|
Gourd, Elizabeth
|
|
|
26 |
5 |
p. 554
|
artikel
|
| 33 |
Outcomes based on risk-adapted adjuvant therapy in postmenopausal women with early breast cancer: a nationwide, prospective cohort study by the Danish Breast Cancer Group
|
Jensen, Maj-Britt
|
|
|
26 |
5 |
p. 654-662
|
artikel
|
| 34 |
Shifting perspectives: a reflection on cancer-specific quality-of-life metrics in cancer care economics
|
Gamper, Eva Maria
|
|
|
26 |
5 |
p. 545-547
|
artikel
|
| 35 |
Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-centre, phase 1 trial
|
Lou, Emil
|
|
|
26 |
5 |
p. 559-570
|
artikel
|
| 36 |
The complex cartography of cancer care
|
The Lancet Oncology,
|
|
|
26 |
5 |
p. 529
|
artikel
|
| 37 |
The Global Platform for Access to Childhood Cancer Medicines: addressing inequities in childhood cancer care
|
Downing, James R
|
|
|
26 |
5 |
p. 540-542
|
artikel
|
| 38 |
Transrectal versus transperineal prostate biopsy: weighing the trade-offs
|
Mian, Badar M
|
|
|
26 |
5 |
p. 533-535
|
artikel
|
| 39 |
Unlocking tumor-infiltrating lymphocyte potential with CRISPR-Cas9
|
Met, Özcan
|
|
|
26 |
5 |
p. 530-531
|
artikel
|
| 40 |
US funding cuts impact cancer care and research
|
Devi, Sharmila
|
|
|
26 |
5 |
p. 552-553
|
artikel
|
| 41 |
US National Firefighter Registry for Cancer shuts down amid layoffs
|
Gruber, Karl
|
|
|
26 |
5 |
p. e240
|
artikel
|
| 42 |
WHO reports health service disruptions due to suspensions of aid
|
Devi, Sharmila
|
|
|
26 |
5 |
p. e241
|
artikel
|
Tijdschrift beschrijving